PDCD1 and head and neck squamous cell carcinoma: One possible solution is to analyze the expression of PD-1/PD-L1 before treatment is initiated, since it could be predictive of efficacy of PD-1/PD-L1 targeted therapy in several tumor types, including HNSCC [88–90].